Erratum: Pan-viral-microRNA screening identifies interferon inhibition as a common function of diverse viruses (Proc Natl Acad Sci USA (2015)(112:13(1856-1861) 10.1073/pnas.1417891112));Pan-viral-microRNA screening identifies interferon inhibition as a common function of diverse viruses

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 6, 2015, Pages 1856-1861

  Coxa, Jennifer E ^a   McClurea, Lydia V ^a   Gogab, Andrei ^b   Sullivana, Christopher S ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

HCMV; KSHV; Latency; P300 CBP; RNAi

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; HISTONE ACETYLTRANSFERASE PCAF; INTERFERON; MICRORNA; PEPTIDES AND PROTEINS; PROTEIN BART 18; RNA PRECURSOR; UNCLASSIFIED DRUG; VIRUS RNA; OLIGONUCLEOTIDE; PRIMER DNA;

ARTICLE; CANCER CELL LINE; CONTROLLED STUDY; DRUG MECHANISM; EPSTEIN BARR VIRUS; HERPESVIRIDAE; HUMAN; HUMAN CELL; LYMPHOCRYPTOVIRUS; NONHUMAN; PRIORITY JOURNAL; ANTAGONISTS AND INHIBITORS; GENE EXPRESSION REGULATION; GENE LIBRARY; GENETICS; HEK293 CELL LINE; METABOLISM; NORTHERN BLOTTING; RETRACTED ARTICLE; SIGNAL TRANSDUCTION; TUMOR CELL LINE; WESTERN BLOTTING;

CERCOPITHECINE HERPESVIRUS 15; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 8;

BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL LINE, TUMOR; DNA PRIMERS; GENE EXPRESSION REGULATION, VIRAL; GENE LIBRARY; HEK293 CELLS; HERPESVIRIDAE; HUMANS; INTERFERONS; MICRORNAS; OLIGONUCLEOTIDES; SIGNAL TRANSDUCTION;

EID: 84922630062     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1504385112     Document Type: Erratum

References (54)

1. Kincaid RP, Sullivan CS (2012) Virus-encoded microRNAs: An overview and a look to the future. PLoS Pathog 8(12):e1003018.
2. Cullen BR (2013) MicroRNAs as mediators of viral evasion of the immune system. Nat Immunol 14(3):205-210.
3. Boss IW, Renne R (2010) Viral miRNAs: Tools for immune evasion. Curr Opin Microbiol 13(4):540-545.
4. Pfeffer S, Voinnet O (2006) Viruses, microRNAs and cancer. Oncogene 25(46):6211-6219.
5. Skalsky RL, Cullen BR (2010) Viruses, microRNAs, and host interactions. Annu Rev Microbiol 64:123-141.
6. Haecker I, et al. (2012) Ago HITS-CLIP expands understanding of Kaposi's sarcomaassociated herpesvirus miRNA function in primary effusion lymphomas. PLoS Pathog 8(8):e1002884.
7. Gottwein E, et al. (2011) Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines. Cell Host Microbe 10(5):515-526.
8. Skalsky RL, Kang D, Linnstaedt SD, Cullen BR (2014) Evolutionary conservation of primate lymphocryptovirus microRNA targets. J Virol 88(3):1617-1635.
9. Riley KJ, et al. (2012) EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency. EMBO J 31(9):2207-2221.
10. Grundhoff A, Sullivan CS (2011) Virus-encoded microRNAs. Virology 411(2):325-343.
11. Cox JE, Sullivan CS (2014) Balance and stealth: The role of noncoding RNAs in the regulation of virus gene expression. Annu Rev Virol 1:89-109.
12. Cullen BR (2011) Herpesvirus microRNAs: Phenotypes and functions. Curr Opin Virol 1(3):211-215.
13. Zhu Y, Haecker I, Yang Y, Gao S-J, Renne R (2013) aγ-Herpesvirus-encoded miRNAs and their roles in viral biology and pathogenesis. Curr Opin Virol 3(3):266-275.
14. Kutok JL, Wang F (2006) Spectrum of Epstein-Barr virus-associated diseases. Annu Rev Pathol 1:375-404.
15. Pfeffer S, et al. (2005) Identification of microRNAs of the herpesvirus family. Nat Methods 2(4):269-276.
16. Cai X, et al. (2006) Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog 2(3):e23.
17. Zhu JY, et al. (2009) Identification of novel Epstein-Barr virus microRNA genes from nasopharyngeal carcinomas. J Virol 83(7):3333-3341.
18. Grundhoff A, Sullivan CS, Ganem D (2006) A combined computational and micro-array-based approach identifies novel microRNAs encoded by human gamma-herpesviruses. RNA 12(5):733-750.
19. Brooks LA, Lear AL, Young LS, Rickinson AB (1993) Transcripts from the Epstein-Barr virus BamHI A fragment are detectable in all three forms of virus latency. J Virol 67(6): 3182-3190.
20. Edwards RH, Marquitz AR, Raab-Traub N (2008) Epstein-Barr virus BART microRNAs are produced from a large intron prior to splicing. J Virol 82(18):9094-9106.
21. Lerner MR, Andrews NC, Miller G, Steitz JA (1981) Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. Proc Natl Acad Sci USA 78(2):805-809.
22. Qiu J, et al. (2011) A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia. PLoS Pathog 7(8):e1002193.
23. Seto E, et al. (2010) Micro RNAs of Epstein-Barr virus promote cell cycle progression and prevent apoptosis of primary human B cells. PLoS Pathog 6(8):e1001063.
24. Vereide DT, et al. (2014) Epstein-Barr virus maintains lymphomas via its miRNAs. Oncogene 33(10):1258-1264.
25. Lopes LF, et al. (2013) Epstein-Barr virus (EBV) microRNAs: Involvement in cancer pathogenesis and immunopathology. Int Rev Immunol 32(3):271-281.
26. Feederle R, et al. (2011) A viral microRNA cluster strongly potentiates the transforming properties of a human herpesvirus. PLoS Pathog 7(2):e1001294.
27. Thompson MP, Kurzrock R (2004) Epstein-Barr virus and cancer. Clin Cancer Res 10(3): 803-821.
28. Rooney CM, Leen AM, Vera JF, Heslop HE (2014) T lymphocytes targeting native receptors. Immunol Rev 257(1):39-55.
29. Rooney C, Leen A (2012) Moving successful virus-specific T-cell therapy for hematopoietic stem cell recipients to late phase clinical trials. Mol Ther - Nucleic Acids 1(11):49-52.
30. Straathof KCM, Bollard CM, Rooney CM, Heslop HE (2003) Immunotherapy for Epstein-Barr virus-associated cancers in children. Oncologist 8(1):83-98.
31. Gutterman JU (1994) Cytokine therapeutics: Lessons from interferon alpha. Proc Natl Acad Sci USA 91(4):1198-1205.
32. Davis CL, et al. (1998) Interferon-alpha treatment of posttransplant lymphoproliferative disorder in recipients of solid organ transplants. Transplantation 66(12):1770-1779.
33. Kiladjian J-J, Mesa RA, Hoffman R (2011) The renaissance of interferon therapy for the treatment of myeloid malignancies. Blood 117(18):4706-4715.
34. Kincaid RP, Burke JM, Cox JC, de Villiers E-M, Sullivan CS (2013) A human torque teno virus encodes a microRNA that inhibits interferon signaling. PLoS Pathog 9(12):e1003818.
35. Kincaid RP, Chen Y, Cox JE, Rethwilm A, Sullivan CS (2014) Noncanonical microRNA (miRNA) biogenesis gives rise to retroviral mimics of lymphoproliferative and immunosuppressive host miRNAs. MBio 5(2):e00074.
36. Lagos D, et al. (2010) miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator. Nat Cell Biol 12(5):513-519.
37. Lin JC, Raab-Traub N (1987) Two strains of Epstein-Barr virus (B95-8 and a P3HR-1 subclone) that lack defective genomes induce early antigen and cause abortive infection of Raji cells. J Virol 61(6):1985-1991.
38. Dölken L, et al. (2010) Systematic analysis of viral and cellular microRNA targets in cells latently infected with human gamma-herpesviruses by RISC immunoprecipitation assay. Cell Host Microbe 7(4):324-334.
39. Marquitz AR, Mathur A, Chugh PE, Dittmer DP, Raab-Traub N (2014) Expression profile of microRNAs in Epstein-Barr virus-infected AGS gastric carcinoma cells. J Virol 88(2):1389-1393.
40. Qiu J, Thorley-Lawson DA (2014) EBV microRNA BART 18-5p targets MAP3K2 to facilitate persistence in vivo by inhibiting viral replication in B cells. Proc Natl Acad Sci USA 111(30):11157-11162.
41. Huang W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4(1):44-57.
42. Cosmopoulos K, et al. (2009) Comprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma. J Virol 83(5):2357-2367.
43. Yang H-J, et al. (2013) Comprehensive profiling of Epstein-Barr virus-encoded miRNA species associated with specific latency types in tumor cells. Virol J 10:314-339.
44. Stern P, et al. (2008) A system for Cre-regulated RNA interference in vivo. Proc Natl Acad Sci USA 105(37):13895-13900.
45. Ebert MS, Neilson JR, Sharp PA (2007) MicroRNA sponges: Competitive inhibitors of small RNAs in mammalian cells. Nat Methods 4(9):721-726.
46. Umbach JL, Strelow LI, Wong SW, Cullen BR (2010) Analysis of Rhesus rhadinovirus microRNAs expressed in virus-induced tumors from infected Rhesus macaques. Virology 405(2):592-599.
47. Takada K, et al. (1991) An Epstein-Barr virus-producer line Akata: Establishment of the cell line and analysis of viral DNA. Virus Genes 5(2):147-156.
48. Ruf IK, Rhyne PW, Yang C, Cleveland JL, Sample JT (2000) Epstein-Barr virus small RNAs potentiate tumorigenicity of Burkitt lymphoma cells independently of an effect on apoptosis. J Virol 74(21):10223-10228.
49. Amoroso R, et al. (2011) Quantitative studies of Epstein-Barr virus-encoded micro-RNAs provide novel insights into their regulation. J Virol 85(2):996-1010.
50. Nachmani D, Stern-Ginossar N, Sarid R, Mandelboim O (2009) Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. Cell Host Microbe 5(4):376-385.
51. Du T, Zhou G, Roizman B (2013) Modulation of reactivation of latent herpes simplex virus 1 in ganglionic organ cultures by p300/CBP and STAT3. Proc Natl Acad Sci USA 110(28):E2621-E2628.
52. Stern-Ginossar N, et al. (2009) Analysis of human cytomegalovirus-encoded microRNA activity during infection. J Virol 83(20):10684-10693.
53. Qi M, et al. (2013) Over-expression of human cytomegalovirus miR-US25-2-3p downregulates eIF4A1 and inhibits HCMV replication. FEBS Lett 587(14):2266-2271.
54. Hertzog PJ, Hwang SY, Kola I (1994) Role of interferons in the regulation of cell proliferation, differentiation, and development. Mol Reprod Dev 39(2):226-232.